In this study, we systemically evaluated the dynamic impacts of a 12-week HFD and high-sucrose feeding on gut microbiota and host metabolism in mice by measuring the body weight gain, serum lipids, hepatic steatosis, glucose tolerance and insulin sensitivity, composition of gut microbiota, and hepatic gene expression profiles. This evidence concerns the gene INS and fatty liver disease.